SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jun 1, 2026

PCSA

Processa Pharmaceuticals, Inc.
BULLISH
Impact 4/10
Horizonweeks Processed4mo ago
Insider cluster: 2 insiders, $9K total
Actionable Insight ▲ Bullish

Insider cluster buys at a micro-cap biotech with strong analyst support are a modest positive signal. Watch for upcoming catalysts (pipeline updates, financing news) that could explain the buying. The small dollar amount limits conviction — treat as a supportive data point, not a standalone trade signal.

DirectionBullish
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d
PCSA ▼ -27.05% at T+60d
LONG call ✗ call lost -27.05% · α vs SPY -28.17% · entry $2.92 → $2.13
Entry = T+0 close
Jun 1, 2026
via day close
T+1d
-4.11%
call -4.11% · α -3.39%
$2.80
settled 5mo ago
T+5d
-30.31%
call -30.31% · α -27.34%
$2.04
settled 5mo ago
T+20d
-32.88%
call -32.88% · α -31.31%
$1.96
settled 4mo ago
T+60d
-27.05%
call -27.05% · α -28.17%
$2.13
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Two C-suite insiders at Processa Pharmaceuticals made open-market purchases totaling ~$9K on May 29, 2026, at $2.57/share. This is a small cluster relative to the $7M market cap (~0.13%), but the fact that both are senior officers buying on the same day at the same price suggests coordinated conviction.

Key Financial Metrics

Direction
buying
Total Value
$8.8K
Insiders
2

Key Facts

  • Chief Administrative Officer Guy Wendy purchased 1,829 shares at $2.57 for $4,701
  • Chief Business & Strategy Officer Lin Patrick purchased 1,582 shares at $2.57 for $4,066
  • Total cluster value: ~$9K, representing ~0.13% of $7M market cap
  • Both trades occurred on the same day (May 29, 2026) at the same price
  • 30-day insider buying totals $33K across 7 transactions
  • Analyst consensus is 86% bullish (6 buy, 1 hold)

Financial Impact

~$9K in insider purchases, ~0.13% of market cap

insider ownershipmarket cap

Risk Factors

  • Micro-cap biotech with $7M market cap — high bankruptcy/dilution risk
  • Small absolute dollar amount ($9K) may reflect liquidity constraints, not strong conviction
  • No disclosed catalyst — buying could be routine accumulation

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-PCSA-1780347459824
14 reports for PCSA
Performance horizon
70% Hit rate @ T+5 7 of 10 directional calls Went positive at some point 9 of 11 best @ T+5▲ +19.60%Mar 31, 2026
Filters
Rows
Reports for PCSA — sortable, filterable
TypeNow
Oct 26, 2026
2d ago
EFFECT
BEARISH ★ 6/10
$1.80awaiting T+5—$1.82 (−1.39%)
Oct 22, 2026
5d ago
DEF 14A
NEUTRAL ★ 4/10
$1.81awaiting T+5—$1.82 (+0.55%)
Oct 9, 2026
18d ago
S-3
BEARISH ★ 7/10
$1.90 $1.73▲ +8.95%▲ +7.45%$1.82 (+4.21%)
Jul 29, 2026
12w ago
8-K
MIXED ★ 6/10
$2.03 $2.19▲ +7.88%▲ +2.35%$1.82 (−10.34%)
Jul 1, 2026
16w ago
Insider Cluster
BULLISH ★ 5/10
$2.16 $2.16· 0.00%▼ −1.37%$1.82 (−15.74%)
Jun 16, 2026
19w ago
Insider Cluster
BULLISH ★ 5/10
$2.15 $1.93▼ −10.23%▼ −9.19%$1.82 (−15.35%)
Jun 16, 2026
19w ago
Insider Cluster
BULLISH ★ 4/10
$2.15 $1.93▼ −10.23%▼ −9.19%$1.82 (−15.35%)
Jun 1, 2026
21w ago
Insider Cluster
BULLISH ★ 4/10
$2.92 $2.04▼ −30.31%▼ −27.34%$1.82 (−37.67%)
May 19, 2026
23w ago
Insider Cluster
BULLISH ★ 5/10
$2.61 $2.64▲ +1.15%▼ −0.65%$1.82 (−30.27%)
May 19, 2026
23w ago
Insider Cluster
BULLISH ★ 5/10
$2.61 $2.64▲ +1.15%▼ −0.65%$1.82 (−30.27%)
Showing 10 of 14

US Market Status

Market Closed — Opens in 9h 11m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 1, 2026